ArticleThe Journal of infection2023

Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis.

Ming Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.